HALOZYME THERAPEUTIC

HALO
Delayed Quote. Delayed  - 06/18 04:00:01 pm
41.41USD -3.56%

Halozyme Therapeutics, Inc. : A support level that should be taken advantage of

06/10/2021 | 02:54am
Nicolas Aleksy
Contributor / Partner

Strategy published on : 06/10/2021 | 02:54

long trade
Live

Entry price : 39.66$
Target : 49.9$
Stop-loss : 32.6$
Potential : 25.82%

The medium term support area around 38.84 USD should allow Halozyme Therapeutics, Inc. shares to re-establish an upward trend in the short term.
Investors have an opportunity to buy the stock and target the $ 49.9.

Summary

● The company has strong fundamentals. More than 70% of listed companies have a lower mix of growth, profitability, debt and visibility criteria.

● For a short-term investment strategy, the company has poor fundamentals.


Strengths

● According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.

● 

● 

● The group's activity appears highly profitable thanks to its outperforming net margins.

● Thanks to a sound financial situation, the firm has significant leeway for investment.

● Over the last twelve months, the sales forecast has been frequently revised upwards.

● Analysts covering this company mostly recommend stock overweighting or purchase.

● The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.


Weaknesses

● Based on current prices, the company has particularly high valuation levels.

● 

● For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.

● 

© MarketScreener.com 2021
Copier lien
All news about HALOZYME THERAPEUTICS, INC.
6d ago
06/08
06/08
05/31
05/28